Share on Pinterest A new drug made by Eli Lilly will be available to treat people with Alzheimer’s disease. Cristina Arias/Cover/Getty Images The U.S. Food and Drug Administration has approved a ...
Kisunla (donanemab) is the second amyloid antibody drug approved to treat early-stage Alzheimer’s disease. The drug slowed cognitive decline by 35 percent compared with placebo, and helped ...
The decision went against the recommendations of the FDA's outside advisory panel The Food and Drug Administration on Monday approved the drug aducanumab as a treatment for Alzheimer’s disease ...
An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration (FDA) advisory panel on Monday. Donanemab is designed to treat symptoms of early Alzheimer’s ...
WASHINGTON — A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild ...